1. Home
  2. PROK vs FTW Comparison

PROK vs FTW Comparison

Compare PROK & FTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.41

Market Cap

316.0M

Sector

Health Care

ML Signal

HOLD

Logo EQV Ventures Acquisition Corp. Class A Ordinary Shares

FTW

EQV Ventures Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$11.21

Market Cap

336.7M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
PROK
FTW
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
316.0M
336.7M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
PROK
FTW
Price
$1.41
$11.21
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.40
N/A
AVG Volume (30 Days)
1.0M
88.4K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$893,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1075.00
N/A
52 Week Low
$1.41
$9.50
52 Week High
$3.48
$17.20

Technical Indicators

Market Signals
Indicator
PROK
FTW
Relative Strength Index (RSI) 34.85 29.24
Support Level N/A $11.12
Resistance Level $2.59 $12.49
Average True Range (ATR) 0.09 0.28
MACD -0.00 -0.02
Stochastic Oscillator 0.03 9.82

Price Performance

Historical Comparison
PROK
FTW

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About FTW EQV Ventures Acquisition Corp. Class A Ordinary Shares

Presidio Production Co is a U.S.-based energy company focused on acquiring, operating and optimizing mature oil and gas assets with a disciplined, technology-driven model.

Share on Social Networks: